FATty liver disease and Gutmicrobial Alcohol Production (FATGAP)
FATGAP aims to investigate the link between gut microbiota, dietary fructose, and NAFLD-NASH, exploring pH effects and developing engineered bacteria for potential treatment.
Projectdetails
Introduction
Obesity and subsequent non-alcoholic hepatic steatosis (NAFLD-NASH) are important determinants of morbidity and mortality, being imbalanced between ethnicities living in Europe. However, relatively little is known about the underlying aetiology that drives NAFLD-NASH, and currently, no treatment is available.
Background
We and others have mapped alterations in gut microbiota to metabolic disease, focusing on the bacterial functions. FATGAP builds on our work showing that 40% of obese humans with NAFLD-NASH are characterized by high production of the (endogenous) microbially produced metabolite ethanol derived from mixed acid fermentation of dietary sugars.
Pilot Data
Our pilot data show that catabolism of the dietary sugar fructose by (small) intestinal high ethanol-producing bacterial strains relates to increased plasma levels of this metabolite. While acidic by-products of mixed acid fermentation lower intestinal pH, thereby inhibiting ethanol production, proton pump inhibitors (PPIs) increase pH. Indeed, epidemiological data have linked PPI use with NAFLD-NASH.
Hypothesis
I therefore hypothesize that gut microbial ethanol production from dietary sugar fructose is intestinal pH dependent and is driven by PPI use in humans.
Objectives
-
Link Gut Microbial Composition/Function
First, I will link gut microbial composition/function in relation to the impact of endogenous (genetic) and exogenous (medication use) factors in microbial ethanol production with NAFLD-NASH in multiethnic prospective cohorts. -
Explore Intestinal pH Variations
Second, we will explore how variations in intestinal pH affect the kinetics by which (labelled) fructose is catabolized into ethanol and how this process is regulated by (inhibitory) strains and microbially produced metabolites. -
Culture Alcohol-Degrading Bacterial Strains
Third, we aim to culture (CRISPRcas modified) alcohol-degrading bacterial strains which can degrade intestinal ethanol at all pH levels. -
Perform Intervention Trials
Finally, I will perform in vivo animal and human intervention trials with these identified (engineered) lead bacterial strains and study the effect in human NAFLD-NASH.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 2.875.663 |
Totale projectbegroting | € 2.875.663 |
Tijdlijn
Startdatum | 1-9-2024 |
Einddatum | 31-8-2029 |
Subsidiejaar | 2024 |
Partners & Locaties
Projectpartners
- STICHTING AMSTERDAM UMCpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Understanding Metabolic Activation of Dendritic Cells in Non-Alcoholic Fatty Liver DiseaseThis project aims to investigate the role of conventional dendritic cells in non-alcoholic steatohepatitis by exploring their immuno-metabolic functions and interactions with liver metabolism. | ERC Starting... | € 2.406.250 | 2022 | Details |
Validation of a new drug target in non-alcoholic steatohepatitisThis project aims to explore oxidative stress's role in non-alcoholic steatohepatitis (NASH) and develop new treatments by targeting MAP kinases p38 and JNK. | ERC Proof of... | € 150.000 | 2023 | Details |
Scalable target identification for metabolic liver diseaseThe 3DMASH project aims to identify novel pharmacological targets for metabolic dysfunction-associated steatohepatitis by mapping tissue interactions using patient-derived organotypic cultures. | ERC Consolid... | € 1.950.000 | 2025 | Details |
Fatty liver versus autoimmunity of the bile ducts - defining the gut signals driving steatosis and inflammatory disease of the gut-liver axisThis project aims to investigate how gut microbiome signals influence the co-occurrence of MASLD and PSC, potentially leading to new diagnostic and therapeutic strategies for liver diseases. | ERC Consolid... | € 2.000.000 | 2025 | Details |
Vascular Control of NASH ProgressionThis project aims to characterize the gut-liver vasculature in NASH progression using spatial sorting and imaging to identify therapeutic targets and prognostic markers for HCC. | ERC Consolid... | € 1.741.250 | 2024 | Details |
Understanding Metabolic Activation of Dendritic Cells in Non-Alcoholic Fatty Liver Disease
This project aims to investigate the role of conventional dendritic cells in non-alcoholic steatohepatitis by exploring their immuno-metabolic functions and interactions with liver metabolism.
Validation of a new drug target in non-alcoholic steatohepatitis
This project aims to explore oxidative stress's role in non-alcoholic steatohepatitis (NASH) and develop new treatments by targeting MAP kinases p38 and JNK.
Scalable target identification for metabolic liver disease
The 3DMASH project aims to identify novel pharmacological targets for metabolic dysfunction-associated steatohepatitis by mapping tissue interactions using patient-derived organotypic cultures.
Fatty liver versus autoimmunity of the bile ducts - defining the gut signals driving steatosis and inflammatory disease of the gut-liver axis
This project aims to investigate how gut microbiome signals influence the co-occurrence of MASLD and PSC, potentially leading to new diagnostic and therapeutic strategies for liver diseases.
Vascular Control of NASH Progression
This project aims to characterize the gut-liver vasculature in NASH progression using spatial sorting and imaging to identify therapeutic targets and prognostic markers for HCC.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Precision nutrition approach for increasing fibre intake and health using microbiota-matched sustainable fibre sourcesFIBRE-MATCH aims to personalize dietary fiber types to gut microbiome subtypes for improved metabolic outcomes and gastrointestinal health in individuals, particularly those with IBS. | EIC Pathfinder | € 3.449.447 | 2024 | Details |
Bugs4Urate - Precision Nutrition Strategies for Investigating Probiotic, Diet, Glycan, and Microbiome Factors in Hyperuricemia and Gout PreventionThis project aims to develop a precision nutrition approach using a novel probiotic to lower urate levels and prevent gout by analyzing gut microbiome interactions and individual responses. | EIC Pathfinder | € 3.765.840 | 2024 | Details |
Precision nutrition approach for increasing fibre intake and health using microbiota-matched sustainable fibre sources
FIBRE-MATCH aims to personalize dietary fiber types to gut microbiome subtypes for improved metabolic outcomes and gastrointestinal health in individuals, particularly those with IBS.
Bugs4Urate - Precision Nutrition Strategies for Investigating Probiotic, Diet, Glycan, and Microbiome Factors in Hyperuricemia and Gout Prevention
This project aims to develop a precision nutrition approach using a novel probiotic to lower urate levels and prevent gout by analyzing gut microbiome interactions and individual responses.